Takashi Azuma

Takashi Azuma

Auto-generated profile, based on publicly available information

Takashi Azuma

Department of Cardiovascular Surgery, Tokyo Women’s Medical University , Tokyo, Japan

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2020 in IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control
Verified
Journal Article
Closed access
TNTakumi Noda
Takumi Noda
NTNaoki Tomii
Naoki Tomii
Keiichi NakagawaKeiichi Nakagawa
Keiichi Nakagawa
TATakashi Azuma
Takashi Azuma
ISIchiro Sakuma
Ichiro Sakuma
A flexible ultrasonic array transducer able to be attached to the body has the potential to achieve long-term continuous unconstrained ultrasound (US) imaging. However, the quality of reconstructed US images is affected by the accuracy of the estimated array shape because the array shape is primitive for time-delay calculation in delay-and-sum beamforming. In this study, we propose an algorithm for estimating the array shape only from the backscattered US signal without using any external device. The proposed algorithm is based on the assumption that beam-summed images reconstructed using an array shape estimated at higher accuracy would have smaller entropy. The array shape is estimated by searching for the shape with minimal entropy, which was used as the index of the beam-summed image quality. Simulation experiments and phantom experiments were used to evaluate the proposed algorithm. In the simulation experiments, three different array shapes with 2.0 MHz, 20 elements, and 0.8 mm pitch transducers were estimated. In the phantom experiments, the array shapes of commercially available linear, convex, and concave transducers were estimated. The results showed that the proposed algorithm can estimate the correct array shape with an average element position error of less than one-eighth of the wavelength of the transmitted signals. These results indicate that the proposed algorithm can achieve sufficiently accurate shape estimation and has the potential to enable clear US imaging with flexible array transducers.

1 July 2010 in Japanese Journal of Applied Physics
Verified
Journal Article
Closed access
MTMarie Tabaru
Marie Tabaru
TATakashi Azuma
Takashi Azuma
KHKunio Hashiba
Kunio Hashiba
Acoustic radiation force (ARF) imaging has been developed as a novel elastography technology to diagnose hepatic disease and breast cancer. The accuracy of shear wave speed estimation, which is one of the applications of ARF elastography, is studied. The Young's moduli of pig liver and foie gras samples estimated from the shear wave speed were compared with those measured the static Young's modulus measurement. The difference in the two methods was 8%. Distance attenuation characteristics of the shear wave were also studied using finite element method (FEM) analysis. We found that the differences in the axial and lateral beam widths in pressure and ARF are 16 and 9% at F-number=0.9. We studied the relationship between two branch points in distance attenuation characteristics and the shape of ARF. We found that the maximum measurable length to estimate shear wave speed for one ARF excitation was 8 mm.

5 July 2020 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
AFAkihisa Furuta
Akihisa Furuta
TATakashi Azuma
Takashi Azuma
YYYoshihiko Yokoi
Yoshihiko Yokoi
SDSatoru Domoto
Satoru Domoto
HNHiroshi Niinami
Hiroshi Niinami
OBJECTIVES: Thoracic endovascular aortic repair (TEVAR) for the treatment of aortic arch disease remains challenging due to certain anatomical and haemodynamic features. The purpose of this study was to evaluate the midterm results of TEVAR with a second-generation fenestrated endograft for aortic arch disease. METHODS: This non-randomized, interventional study was part of a multicentre clinical trial conducted between 2010 and 2011 and was designed to assess the effectiveness of a second-generation precurved fenestrated endograft for aortic arch disease. Midterm data collected during the fifth postoperative year from 205 patients treated with this endograft with the proximal landing of zone 0 or 1 were assessed regarding survival, reoperation and complications. RESULTS: The initial and technical success rates were 94% and 91%, respectively. Ninety-seven percent of patients were treated using zone 0. The rate of in-hospital deaths was 3%. Overall survival was 71% at 5 years; thoracic aorta-related death-free survival rates at 1 and 5 years after surgery were 99.5% and 97.8%, respectively. Aneurysm-related event-free survival rates at 1 and 5 years after surgery were 86.8% and 77.1%, respectively. Reoperation-free survival rates at 5 years were 86.6%. The most frequent reason for reoperation was type Ia endoleak (5%), followed by type II endoleak (2%). Incidences of cerebral infarction, device migration, spinal cord ischaemia and supra-aortic branch stenosis were 6%, 1%, 1% and 1%, respectively. CONCLUSIONS: The precurved fenestrated endograft provided appropriate conformability to the aortic arch and made zone 0 landing possible with simplified, less-invasive manipulations. The midterm results of TEVAR with this endograft suggest this method is a valuable endovascular treatment option for aortic arch disease. Clinical trial registration number: UMIN000007213.

17 March 2015
Verified
Conference Paper
Closed access
PDF file
XQXiaolei Qu
Xiaolei Qu
TATakashi Azuma
Takashi Azuma
HNHirofumi Nakamura
Hirofumi Nakamura
HIHaruka Imoto
Haruka Imoto
STSatoshi Tamano
Satoshi Tamano
YMYoichiro Matsumoto
Yoichiro Matsumoto

10 February 2022 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
TATakashi Azuma
Takashi Azuma
YYYoshihiko Yokoi
Yoshihiko Yokoi
NHNamiko Hayakawa
Namiko Hayakawa
SDSatoru Domoto
Satoru Domoto
HNHiroshi Niinami
Hiroshi Niinami
OBJECTIVES: We devised a novel physician-modified endograft (PMEG) with hydrogel-reinforced fenestrations to provide a more secure connection with the bridging graft than fenestrations alone. We applied this novel PMEG in a clinical setting and evaluated the clinical and technical results. METHODS: In this study, patients with complex thoraco-abdominal aortic pathologies involving the renal, superior mesenteric or coeliac artery were included. However, patients with pararenal abdominal aneurysm were excluded. Regardless of anatomical suitability, all patients referred to our hospital were enrolled. All patients were treated via compassionate use of PMEG. All PMEGs were used following the same procedure using hydrogel-reinforced fenestrations. A retrospective analysis was conducted on consecutive patients who were treated between October 2018 and April 2021. RESULTS: Out of 40 patients, 29 and 11 were men and women, respectively. The median patient age was 73.6 (range: 49–87) years. Among the patients, 36 (90%) had true aneurysms, whereas the others had false lumen aneurysms and penetrating atherosclerotic ulcer. Despite anatomical challenges, all branches were successfully reconstructed. The mean operative time was 333 (standard deviation 98) min. Postoperative computed tomography angiography did not reveal type I and IIIc endoleaks from the hydrogel-reinforced fenestrations. The 30-day survival rate was 97.5%. One patient died due to brain haemorrhage on postoperative day 5. During follow-up, computed tomography revealed no migration of any bridging graft. CONCLUSIONS: We confirmed the effectiveness of the hydrogel as a sealing material and the secure connection between hydrogel-reinforced fenestrations and side branches in vivo. Clinical trial registration number: 5287.

27 February 2019 in General Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
SDSatoru Domoto
Satoru Domoto
TATakashi Azuma
Takashi Azuma
YYYoshihiko Yokoi
Yoshihiko Yokoi
SISyogo Isomura
Syogo Isomura
KTKen Takahashi
Ken Takahashi
HNHiroshi Niinami
Hiroshi Niinami